BiotechTube
Home/Maze Therapeutics/Harold Bernstein
HB

Harold Bernstein

President, Research and Development and Chief Medical Officer

Maze Therapeutics

Therapeutic Areas

RenalCardiometabolicMetabolic Disorders

Maze Therapeutics Pipeline

DrugIndicationPhase
MZE829APOL1-Mediated Kidney Disease (AMKD)Phase 2
MZE782Chronic Kidney Disease (CKD) and Phenylketonuria (PKU)Phase 1/Discovery
Undisclosed GLP-1RAObesityDiscovery/Preclinical

Leadership Team at Maze Therapeutics

JC
Jason Coloma
Chief Executive Officer
MT
Misbah Tahir
Chief Financial Officer
CP
Courtney Phillips
General Counsel & Corporate Secretary
AD
Atul Dandekar
Chief Strategy & Business Officer
View full Maze Therapeutics profile